Analyst Color - Spark Newswire

2 minute read

Why This dLocal Analyst Is Bullish On Fintech Stock

Today, 9:40 PM

The driver of Uruguayan fintech company DLocal Ltd's (NASDAQ: DLO) growth is its ability simplify payments by addressing pain points in emerging markets, according to. BofA Securities analyst.

DLO

2 minute read

July 4 Weekend Room Rates In Las Vegas Now 50% Above Pre-Pandemic Levels

By Wayne Duggan

Today, 9:40 PM

It’s been a long road back for Las Vegas casinos since the pandemic hit last year, but one metric suggests next weekend could be a big weekend for Vegas.

CZR

2 minute read

Why This MindMed Analyst Is Bullish: ‘One Of The Most Diverse Pipelines In Psychedelics’

By Wayne Duggan

Today, 9:40 PM

Mind Medicine (MindMed) Inc (NASDAQ: MNMD) shares traded higher by 3.3% on Monday after one analyst initiated bullish coverage of the psychedelics stock. The Analyst: Maxim analyst Jason McCarthy initiated coverage of MindMed with a Buy rating and $6 price target.

MNMD

2 minute read

Why Tesla’s China Recall Is A ‘Black Eye’ Moment For The EV Maker In The Key Region

By Shanthi Rexaline

Today, 9:40 PM

Tesla Inc (NASDAQ: TSLA) is facing a setback in China, a region that is key to its growth plans going forward. The Tesla Analyst: Wedbush analyst Daniel Ives has an Overweight rating and a $1,000 price target for Tesla shares.

TSLA

2 minute read

JNJ’s $260M Settlement Could Serve As Global Opioid Deal Template: Analyst

By Wayne Duggan

Today, 9:40 PM

Over the weekend, Johnson & Johnson (NYSE: JNJ) reached a major opioid litigation settlement that could have broader implications for the biopharmaceutical industry.

ABC

1 minute read

Medicenna Therapeutics Shares Spike To Session High, Now Up 6%, As Traders Circulate Buy Rating, $12 Price Target From Zacks

By Benzinga Newsdesk

Today, 9:40 PM

https://s27.q4cdn.com/906368049/files/News/2021/Zacks_SCR_Research_06282021_MDNA_Bautz.pdf

MDNA

2 minute read

Why Intellia Therapeutics Stock Is Soaring Today

By Adam Eckert

Today, 9:40 PM

Intellia Therapeutics Inc (NASDAQ: NTLA) is trading significantly higher Monday morning after the company announced positive clinical data for its CRISPR therapy.

NTLA

2 minute read

5 FedEx Analysts Break Down Q4 Earnings: ‘We Continue To See Upside Potential’

By Wayne Duggan

Today, 9:40 PM

FedEx Corporation (NYSE: FDX) traded lower by 4% on Friday after the company delivered lackluster fiscal fourth-quarter numbers on Thursday afternoon.

FDX

3 minute read

Nike Has Long Runway Growth With Focus On Direct Sales, Margin Growth: Analyst React To Q4

By Chris Katje

Today, 9:40 PM

Shares of Nike Inc (NYSE: NKE) hit a 52-week high Friday after reporting a strong fourth quarter that beat Street consensus. Here is the reaction from analysts on the key takeaways from the earnings report and if Nike has more room to run.

NKE

2 minute read

Virgin Galactic Could Push For Sir Richard Branson To Join Crewed Flight: Analyst

By Chris Katje

Today, 9:40 PM

Shares of Virgin Galactic traded higher Friday after receiving FAA certification to take passengers to space. A Virgin Galactic analyst discussed the possibility of founder Sir Richard Branson flying into space in a new note.

AMZN